To evaluate whether or not the studies of the late/chronic EAE have implications for human MS, we examined Eomes expression by CD4+ T cells in peripheral blood mononuclear cells (PBMCs) derived from healthy controls (HCs), or patients with either RRMS or SPMS. The gene discussed is CD4; the disease is myeloid sarcoma.